Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × BNT162 Vaccine × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Propofol 8 Sevoflurane 6 Dexamethasone 6 Rituximab 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 Bevacizumab 4 pembrolizumab 3 Trastuzumab 3 Surgical Procedures, Operative 3 Standard of Care 3 Saline Solution 3 Metformin 3 Letrozole 3 Lenalidomide 3 Gemcitabine 3 Fluorouracil 3 Enoxaparin 3 Carboplatin 3 Acetaminophen 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 semaglutide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡